Stay updated with breaking news from Barnaby Balmforth. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Biofidelity, a pioneer in precision cancer diagnostics, has expanded its Scientific Advisory Board to include Lee N. Newcomer, MD, an...
Lawmakers have acted to strengthen insurance reimbursement for biomarker testing in California, Illinois and Louisiana. Patient advocates and testing companies hope more will act in the coming year.
/PRNewswire/ -- Biofidelity, a pioneer in precision cancer diagnostics, today praised California Governor Gavin Newsom and the California legislature for the...
· Global clinical lead for the Pfizer SMO Inhibitor, Daurismo, from pre-IND to FDA approval · Clinical development and medical affairs leadership for multiple publicly-traded and private companies Cambridge, UK 28 January 2021 - Biofidelity Ltd, the cancer diagnostics company, today announces the appointment of Wendy J. Levin MD MS as Chief Medical Officer, based in the US. Following Biofidelity's recent Series A financing, supported by experienced investors BlueYard Capital, Longwall Ventures and Agilent Technologi...
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Biofidelity appoints Robert Osborne as Chief Operating Officer Biofidelity LimitedDecember 10, 2020 GMT CAMBRIDGE, United Kingdom, Dec. 10, 2020 (GLOBE NEWSWIRE) -- Biofidelity Ltd, the cancer diagnostics company, today announces the further expansion of its leadership team with the appointment of Dr. Robert Osborne as Chief Operating Officer. In addition to responsibility for the overall operation of the business at a time of rapid growth, Dr. Osborne will lead product development and validation, o...